RESÚMENES MAYO 2007

.

Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

 

Cross–national prevalence and correlates of adult attention–deficit hyperactivity disorder

J. Fayyad, R. De Graaf, R. Kessler, J. Alonso, M. Angermeyer, K. Demyttenaere, G. De Girolamo, J. M. Haro, E. G. Karam, C. Lara, J.-P. Lépine, J. Ormel, J. Posada-Villa, A. M. Zaslavsky and R. Jin

The British Journal of Psychiatry (2007) 190: 402-409

Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: Efficacy, safety and cognitive function
Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W

Eur Psychiatry. 2007 May 3; [Epub ahead of print] 

All–cause mortality among recipients of electroconvulsive therapy. Register-based cohort study

Trine Munk-Olsen, Thomas Munk Laursen, Poul Videbech, Preben Bo Mortensen, Raben Rosenberg

The British Journal of Psychiatry (2007) 190: 435-439

Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours. Discontinuation study

Frank Haessler, Thomas Glaser, Manfred Beneke, Akos F. Pap, Ralf Bodenschatz, Olaf Reis, on behalf of the Zuclopenthixol Disruptive Behaviour Study Group

The British Journal of Psychiatry (2007) 190: 447-448

 

Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

Original Paper

Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

Nicholas J. Talley, John E. Kellow, Philip Boyce, Christopher Tennant, Sandy Huskic and Michael Jones

Digestive Diseases and Sciences 2007; Online: Tuesday, May 15, 2007

 

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials

Ira Katz, Peter-Paul de Deyn, Jacobo Mintzer, Andrew Greenspan, Young Zhu, Henry Brodaty

International Journal of Geriatric Psychiatry. Volume 22, Issue 5, Pages 475 - 484

 

A Randomized, Controlled, Trial of Controlled Release Paroxetine in Fibromyalgia

Ashwin A. Patkar, Prakash S. Masand, Stan Krulewicz, Paolo Mannelli, Kathleen Peindl, Katherine L. Beebe and Wei Jiang

The American Journal of Medicine. Volume 120, Issue 5, May 2007, Pages 448-454       

 

Prevalence of Major Psychiatric Illness in Young Adults Who Were Burned as Children

Walter J. Meyer, Patricia Blakeney, Christopher R. Thomas, William Russell, Rhonda S. Robert, and Charles E. Holzer

Psychosomatic Medicine 69:377-382 (2007)

Obesity, migraine, and chronic migraine. Possible mechanisms of interaction

Marcelo E. Bigal, Richard B. Lipton, Philip R. Holland, and Peter J. Goadsby

NEUROLOGY 2007;68:1851-1861

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

ADAPT Research Group

NEUROLOGY 2007;68:1800-1808

Effects of the association of Sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease

H. Ollat, B. Laurent, S. Bakchine, B.-F. Michel, J. Touchon, B. Dubois

L’Encephale. Vol 33 - N° 2 - Avril 2007: p. 211 - 215

Selective Serotonin Reuptake Inhibitor Use by Patients with Acute Coronary Syndromes

Roy C. Ziegelstein, Jennifer Meuchel, Thomas J. Kim, Madiha Latif, William Alvarez, Neela Dasgupta and Brett D. Thombs

The American Journal of Medicine. Volume 120, Issue 6, June 2007, Pages 525-530

 

Olanzapine therapy in anorexia nervosa: psychobiological effects

Brambilla, Francesca; Garcia, Cristina Segura; Fassino, Secondo; Daga, Giovanni Abbate; Favaro, Angela; Santonastaso, Paolo; Ramaciotti, Carla; Bondi, Emilia; Mellado, Carmen; Borriello, Renata; Monteleone, Palmiero

International Clinical Psychopharmacology. 22(4):197-204, July 2007

Psychogenic Polydipsia Review: Etiology, Differential, and Treatment

Brian Dundas, Melissa Harris, and Meera Narasimhan

Current Psychiatry Reports 2007, 9:236-241

 

Completed Suicide in Medical/Surgical Patients: Who is at Risk?

J. Michael Bostwick and Sandra J. Rackley

Current Psychiatry Reports 2007, 9:242-246

 

Auditory Hallucinations in Those Populations That Do Not Suffer from Schizophrenia

C. Choong, M. D. Hunter, and P.W.R. Woodruff

Current Psychiatry Reports 2007, 9:206-212

 

Intramuscular Aripiprazole in the Control of Agitation

CURRIER, GLENN W; CITROME, LESLIE L; ZIMBROFF, DAN L; OREN, DAN; MANOS, GEORGE; MCQUADE, ROBERT; PIKALOV, ANDREI A. III; CRANDALL, DAVID T

Journal of Psychiatric Practice. 13(3):159-169, May 2007

Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study

Yves Le Bloc'h;  Pierre Baumann;  Michael Stigler;  Chin B. Eap; Daniele F. Zullino

International Journal of Psychiatry in Clinical Practice, Volume 11, Issue 2 2007 , pages 123 - 128

 

Treatment of the mild cognitive impairment (MCI)

Hervé Allain, Danièle Bentué-Ferrer, Yvette Akwa

Human Psychopharmacology: Clinical and Experimental. Volume 22, Issue 4, Pages 189 - 197

 

Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine

D. O. Kennedy, C. F. Haskell, P. L. Mauri, A. B. Scholey

Human Psychopharmacology: Clinical and Experimental. Volume 22, Issue 4, Pages 199 - 210

 

Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function

Cyndya Shibao; Satish R. Raj; Alfredo Gamboa; André Diedrich; Leena Choi; Bonnie K. Black; David Robertson; and Italo Biaggioni

Hypertension 2007, May 2007

 

A systematic review of valerian as a sleep aid: Safe but not effective

Diana M. Taibi, Carol A. Landis, Heidi Petry and Michael V. Vitiello

Sleep Medicine Reviews. Volume 11, Issue 3, June 2007, Pages 209-230

 

Prodromal non-motor symptoms of Parkinson's disease

Clelia Pellicano | Dario Benincasa | Vincenzo Pisani | Francesca R Buttarelli | Morena Giovannelli | Francesco E Pontieri

 Neuropsychiatric Disease and Treatment. Volume: 3 | Issue: 1: 145-151

 

The four As associated with pathological Parkinson disease gamblers: anxiety, anger, age, and agonists

Michael A Shapiro | Yu Ling Chang | Sarah K Munson | Charles E Jacobson IV | Ramon L Rodriguez | Frank M Skidmore | Michael S Okun | Hubert H Fernandez

 Neuropsychiatric Disease and Treatment. Volume: 3 | Issue: 1: 161-167

 

Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate
Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK, Van Someren EJ

Sleep. 2007 Apr 1;30(4):433-42

Efficacy and safety of atypical antipsychotics in dementia: a sistematic review

Melissa Guarieiro Ramos e Fábio Lopes Rocha

J Bras Psiquiatr, 55(3): 218-224, 2006

TEXTO GRATUITO

 

Do Some Children Diagnosed with Oppositional Defiant Disorder Develop Querulous Disorder?

Sheridan G. Tucker, Ronald A. Weller, Connie L. Petersen, and Elizabeth B. Weller

Current Psychiatry Reports 2007, 9: (2) 99-105

TEXTO GRATUITO (previa suscripción)

 

Experimentos clínicos aleatorizados, o cómo evaluar las intervenciones

Álvaro J. Ruiz Morales, Lina María Vargas Abello

Revista Colombiana de Psiquiatría, vol. XXXVI / No. 1 / 2007:145-153

TEXTO GRATUITO

 

A review of compulsive buying disorder

DONALD W BLACK

World Psychiatry. 2007 February; 6(1): 14–18

TEXTO GRATUITO

 

Personality disorders in somatization disorder patients: A controlled study in Spain

Javier Garcia-Campayo, Marta Alda, Natalia Sobradiel, Barbara Olivan, Aida Pascual

J Psychosom Res. Volume 62, Issue 6, Pages 675-680 (June 2007)

 

Behavioral and Subjective Effects of d-Amphetamine and Modafinil in Healthy Adults

Angela P. Makris, Craig R. Rush, Robert C. Frederich, Alisia C. Taylor and Thomas H. Kelly

Experimental and Clinical Psychopharmacology. Volume 15, Issue 2, April 2007, Pages 123-133

.

Regresar a RESÚMENES MAYO 2007